Twenty -three patients with end-stage renal failure due to diabetic nephropathy received renal replacement treatment. All patients had insulin -dependent diabetes mellitus. Nineteen transplants were performed in seventeen patients. Two-year graft survival for all transplants was 74 % with a two -year patient survival posttransplantation of 81 %. Overall two -year patient survival was 73 %, compared with 82 % in non -diabetic patients receiving renal replacement treatment. In diabetic patients accepted for treatment there was a high incidence of non -renal
INTRODUCTION
The diagnosis of diabetic nephropathy in an individual diabetic patient is usually presumed in the presence of proteinuria and impaired renal function in association with diabetic retinopathy. Hypertension is almost invariably present at some stage and common histological features are diffuse and nodular glomerulosclerosis. The nephropathy may be compounded by other diabetic renal complications such as atheromatous renovascular disease, pyelonephritis, papillary necrosis and neurogenic bladder. The prevalence of diabetic nephropathy increases with the duration of diabetes to a peak of around 20% after 20-25 years.1 After 25 years the annual incidence declines, indicating that the development of nephropathy is not solely dependent on the duration of diabetes.2 Renal failure secondary to diabetic nephropathy was responsible for over one quarter of the deaths in one study3 of patients in whom insulin -dependent diabetes mellitus was diagnosed before 31 years of age. This and other similar studies4 5 There was a high prevalence of non -renal diabetic complications in patients at the time of referral (Table) . Retinopathy was present in all and 70 % had received laser photocoagulation for proliferative retinopathy; 22 % were registered blind. Cardiovascular disease was common: ECG recordings were reviewed by one investigator (APM) -78% had an abnormal ECG, and 30% had the electrocardiographic criteria for a previous myocardial infarction. Angina pectoris was present in 22 %, and hypertension (BP >150 / 90) in 96%. The prevalence of cerebrovascular disease was lower, 9% having had a completed stroke while carotid bruits were heard in 9% . Evidence of peripheral neuropathy was found in 57 % based on clinical symptoms and signs, and nerve conduction studies in 13% of these patients confirmed the clinical diagnosis. Peripheral vascular disease had produced considerable morbidity in 34% of patients, and aboveknee amputations had been required in 8% (two cases). Three further patients had above -knee amputations shortly after commencing renal replacement treatment.
RENAL REPLACEMENT THERAPY
The mean age for commencing treatment was 38 years. Dialysis therapy was started in 60 % of patients for refractory pulmonary oedema or hypertension, and in a further 30% for uraemic symptoms. , diabetic patients accounted for 12 % of the total treated, indicating that increasing numbers of diabetic patients are receiving renal replacement therapy. Some diabetic patients who were referred in the period reported were not treated for reasons of advanced age, dependency and overwhelming medical complications. These criteria were equally applied to non -diabetic patients referred for assessment and reflect earlier restrictions on the provision of care for patients with renal failure. The number of diabetic patients with renal impairment in Northern Ireland is unknown as the recent survey '0 only selected for study diabetics with advanced renal failure (serum creatinine >500 pmol/l and urea > 25 mmol/l ). Most of the patients reported here were referred at a late stage of their renal disease and required renal replacement, on average, within a year. Pulmonary oedema and hypertension were the main indications for starting treatment. A high incidence of non -renal diabetic complications was evident which posed many management problems. While vascular disease did not prove a contraindication to renal replacement treatment, our experience suggests that an aggressive approach to this frequently co -existing problem is essential. Myocardial infarction was implicated in 50% of the deaths in diabetic patients in the period reported. Significant ischaemic heart disease may be present 12 without symptoms, often declaring itself only after treatment for end -stage renal failure has commenced. Two patients with multi -vessel coronary artery disease, which became symptomatic on haemodialysis treatment, underwent coronary artery bypass grafting procedures. These patients were managed post -operatively by peritoneal dialysis and later trained for continuous ambulatory peritoneal dialysis. Some centres have recommended coronary artery angiography as a routine pre-transplant screening procedure in diabetic uraemic patients 13 and others have reported that diabetic patients with significant coronary artery disease had a worse prognosis for all modalities of treatment but a trend to better survival following transplantation. ' 
